Adam Margolin

Adam Margolin is a Venture Partner at KV where he focuses on creation of life sciences companies aimed at leveraging advanced data and technology driven approaches to accelerate drug discovery and precision medicine. By joining KV, Adam has returned to his original passion for business and entrepreneurship, which led him to pursue a bachelor’s degree at the Wharton School of Business. After working briefly on Wall Street, Adam became fascinated by the promise of genomic sequencing technologies that emerged through the Human Genome Project. He decided that analyzing DNA, rather than stocks and bonds, would offer a more interesting and rewarding career path. Over the next 20 years, Adam performed highly influential work in computational biology and cancer research and rose to lead some of the largest and most successful research organizations in these areas.

Most recently, Adam was Chair and Professor of the Department of Genetics and Genomic Sciences, Director of the Icahn Institute for Data Science and Genomic Technology, and Senior Associate Dean of Precision Medicine at Mount Sinai. In these roles, Adam led an organization that rose to become the #3 ranked genetics department in the country, encompassing over 700 people and over $100M annual revenue. Concurrently, Adam served as Chief of Data Science of Sema4, and contributed to the company achieving two successful funding rounds yielding a valuation over $1B.

Prior to Mount Sinai, Adam was the Founding Director of the Computational Biology program at Oregon Health & Science University, where he was also promoted to the rank of Tenured Full Professor. Previously, Adam was Director of Computational Biology and co-Leader of Strategy at Sage Bionetworks.

Adam is an internationally recognized researcher in the fields of computational biology and cancer research, as evidenced by 28 funded projects, an active publication record, and development of widely used methods that have been ranked among the most influential algorithms in the field of computational biology.

Adam performed his postdoctoral research at the Broad Institute of Harvard and MIT and obtained his PhD. from Columbia University. He also holds a master’s degree in Computer Science from the University of Pennsylvania.